Antivenin represents a groundbreaking solution for managing snake envenomation in animals, offering a potent and versatile treatment option. Stored frozen and boasting a shelf life of three years from the manufacture date, this ready-to-use antivenin streamlines the treatment process, requiring only five minutes to thaw using a warm water bath, without the need for reconstitution or dilution.
Crafted to provide cross-protective efficacy, Antivenin has demonstrated remarkable effectiveness against envenomation in both canines and equines caused by North American Crotalidae, encompassing various species such as cottonmouths/water moccasins, copperheads, and rattlesnakes. Its ability to neutralize venom is complemented by its convenient packaging in a “one-and-done” IV pouch, delivering a potent 50 mL dose capable of addressing typical envenomation cases in a single administration, irrespective of the animal’s size.
Beyond neutralizing venom, Antivenin offers comprehensive symptom relief, including reducing swelling, alleviating pain, and lowering temperature, thereby facilitating faster recovery and minimizing hospitalization time. Notably, it is the only licensed product featuring specific antibodies proven to neutralize Mohave Venom A, enhancing its efficacy against a broader spectrum of snake venoms.
Furthermore, Antivenin is the sole antivenin licensed for use in both canines and equines, ensuring versatility and accessibility across veterinary settings. Its safety profile extends to compatibility with typical post-snake bite therapies and vaccination protocols, making it a reliable adjunct to comprehensive treatment strategies.
Manufactured in the USA, Antivenin marks a significant milestone as the first approved and USDA licensed antivenin produced domestically in over a decade, embodying a commitment to quality, efficacy, and innovation in veterinary medicine.
Reviews
There are no reviews yet.